Dexco Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 0/6
DexcoDie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -41.2% zurückgegangen, während in der Branche Forestry die Gewinne mit einer durchschnittlichen jährlichen Rate von 1.2% zurückgehen. Die Umsatzerlöse sind gewachsen mit einer durchschnittlichen Rate von 1.3% pro Jahr. Dexco Die Eigenkapitalrendite des Unternehmens beträgt 1%, und die Nettomargen liegen bei 0.1%.
Wichtige Informationen
-41.19%
Wachstumsrate der Gewinne
-41.80%
EPS-Wachstumsrate
| Forestry Wachstum der Industrie | 45.90% |
| Wachstumsrate der Einnahmen | 1.27% |
| Eigenkapitalrendite | 1.04% |
| Netto-Marge | 0.10% |
| Nächste Ertragsaktualisierung | 06 Aug 2026 |
Jüngste Aktualisierungen vergangener Leistungen
Analyseartikel • May 18
Dexco's (BVMF:DXCO3) Weak Earnings May Only Reveal A Part Of The Whole Picture
Dexco S.A.'s ( BVMF:DXCO3 ) stock showed strength, with investors undeterred by its weak earnings report. We think that...Analyseartikel • Nov 13
Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. We think that...Analyseartikel • Mar 21
Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. Our analysis...Recent updates
Analyseartikel • May 18
Dexco's (BVMF:DXCO3) Weak Earnings May Only Reveal A Part Of The Whole Picture
Dexco S.A.'s ( BVMF:DXCO3 ) stock showed strength, with investors undeterred by its weak earnings report. We think that...
Narrativ-Update • May 02
DXCO3: Future Stock Split Will Support More Attractive Multiple Repricing Outlook
Analysts have raised their price target on Dexco from approximately R$7.16 to about R$7.28, citing updated assumptions regarding the discount rate, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value: R$7.16 to R$7.28, representing a small upward adjustment in the modelled target price range.
Narrativ-Update • Apr 18
DXCO3: Higher Revenue Outlook And Richer Future P/E Will Support Upside
Analysts have raised their valuation of Dexco, increasing the fair value estimate from R$8.70 to R$9.00. The change reflects updated assumptions that include higher revenue growth expectations, a lower discount rate and a richer future P/E multiple, partly offset by a lower projected profit margin.Narrativ-Update • Apr 04
DXCO3: Future Stock Split Will Support A More Attractive Repricing Outlook
Analysts have slightly adjusted their R$ price target on Dexco, citing updated assumptions that combine a different fair value estimate with changes to revenue growth, profit margin expectations and a higher future P/E multiple. Valuation Changes Fair Value: R$7.22 in the previous model compared with R$7.16 in the updated assumptions.
Narrativ-Update • Mar 21
DXCO3: Planned Stock Split And Margin Outlook Will Support Future Upside
Analysts have kept their R$ fair value estimate for Dexco steady at R$5.36. Updated assumptions reflect a slightly higher discount rate, a marginally lower revenue growth outlook, a modestly stronger profit margin, and a similar future P/E expectation.Narrativ-Update • Mar 06
DXCO3: Planned Stock Split Will Support Positive Long Term Outlook
Analysts have revised their R$ price target for Dexco slightly, with the change grounded in updated assumptions that include a different discount rate, adjusted revenue growth and profit margin expectations, and a revised future P/E multiple. What's in the News Dexco plans a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).Narrativ-Update • Feb 20
DXCO3: Future Stock Split Will Support A More Attractive Share Repricing
Analysts have trimmed their R$ price target for Dexco, reflecting a slightly lower fair value estimate alongside updated assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News Dexco announced a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).Narrativ-Update • Feb 06
DXCO3: Stock Split And Conservative Earnings Profile Will Support Future Upside
Analysts have reduced their fair value estimate for Dexco from about $8.81 to $8.70 per share. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E, which collectively indicate a more conservative earnings profile than previously estimated.Narrativ-Update • Jan 23
DXCO3: Future Split And Revised Assumptions Will Shape Balanced Outlook
Analysts have reduced their fair value estimate for Dexco from US$6.00 to US$5.36, citing updated assumptions for revenue growth, profit margins, the discount rate, and a lower future P/E multiple. What's in the News Dexco has announced a stock split or significant stock dividend with a 1.12 to 1 ratio, scheduled for December 26, 2025 (Key Developments).Analyseartikel • Jan 23
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Narrativ-Update • Jan 08
DXCO3: Future Margins And Stock Split Plan Will Support Upside
Analysts have adjusted their price target for Dexco, reflecting a fair value change from $9.83 to $8.81. This shift is tied to updated assumptions for revenue growth, profit margins and future P/E expectations.Analyseartikel • Dec 25
Dexco S.A. (BVMF:DXCO3) Not Flying Under The Radar
With a price-to-earnings (or "P/E") ratio of 41.1x Dexco S.A. ( BVMF:DXCO3 ) may be sending very bearish signals at the...Narrativ-Update • Dec 23
DXCO3: Stronger Future Margins And Investor Day May Drive Upside
Analysts have adjusted their price target on Dexco from R$10.00 to roughly R$9.83 per share. This reflects slightly lower revenue growth assumptions, stronger expected profit margins, and a more conservative future valuation multiple.Analyseartikel • Nov 13
Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. We think that...Analyseartikel • Oct 06
Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Narrativ-Update • Sep 06
Urbanization Trends And Digital Platforms Will Expand Market Reach
With both revenue growth and net profit margin forecasts holding steady, Dexco’s analyst consensus fair value remains unchanged at R$8.00. Valuation Changes Summary of Valuation Changes for Dexco The Consensus Analyst Price Target remained effectively unchanged, at R$8.00.Analyseartikel • Mar 21
Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. Our analysis...Analyseartikel • Mar 15
Dexco S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Shareholders might have noticed that Dexco S.A. ( BVMF:DXCO3 ) filed its full-year result this time last week. The...
Neues Narrativ • Mar 10
New Ceramic Tiles Factory In Botucatu Will Improve Future Operations
Streamlining of operations could enhance focus on core areas, boosting profitability and improving net margins.Analyseartikel • Feb 12
Here's Why Dexco (BVMF:DXCO3) Has A Meaningful Debt Burden
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analyseartikel • Dec 20
Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?
While Dexco S.A. ( BVMF:DXCO3 ) might not have the largest market cap around , it saw significant share price movement...Analyseartikel • Dec 02
There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price
When close to half the companies in Brazil have price-to-earnings ratios (or "P/E's") below 8x, you may consider Dexco...Analyseartikel • Oct 26
Is Dexco (BVMF:DXCO3) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Aug 10
Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results
Shareholders of Dexco S.A. ( BVMF:DXCO3 ) will be pleased this week, given that the stock price is up 12% to R$8.05...Analyseartikel • Aug 08
Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching
Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a decent share price growth of 14% on the...Analyseartikel • Jul 19
Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Analyseartikel • May 13
Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts
Last week saw the newest quarterly earnings release from Dexco S.A. ( BVMF:DXCO3 ), an important milestone in the...Analyseartikel • May 04
Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?
Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a double-digit share price rise of over 10...Analyseartikel • Apr 15
Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Analyseartikel • Mar 14
Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem
Shareholders didn't seem to be thrilled with Dexco S.A.'s ( BVMF:DXCO3 ) recent earnings report, despite healthy profit...Analyseartikel • Jan 19
Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors
With a price-to-earnings (or "P/E") ratio of 7.5x Dexco S.A. ( BVMF:DXCO3 ) may be sending bullish signals at the...Analyseartikel • Jan 04
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyseartikel • Dec 04
At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?
Dexco S.A. ( BVMF:DXCO3 ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...Analyseartikel • Oct 08
Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Analyseartikel • Sep 13
Is Dexco (BVMF:DXCO3) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Aufschlüsselung der Einnahmen und Ausgaben
Aufschlüsselung der Einnahmen und Ausgaben
Wie Dexco Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Gewinn | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 31 Mar 26 | 8,365 | 9 | 1,516 | 0 |
| 31 Dec 25 | 8,249 | 1 | 1,530 | 0 |
| 30 Sep 25 | 8,216 | 111 | 1,530 | 0 |
| 30 Jun 25 | 8,327 | 193 | 1,581 | 0 |
| 31 Mar 25 | 8,201 | 258 | 1,563 | 0 |
| 31 Dec 24 | 8,235 | 172 | 1,545 | 0 |
| 30 Sep 24 | 8,119 | 337 | 1,533 | 0 |
| 30 Jun 24 | 7,649 | 542 | 1,471 | 0 |
| 31 Mar 24 | 7,607 | 602 | 1,475 | 0 |
| 31 Dec 23 | 7,383 | 790 | 1,428 | 0 |
| 30 Sep 23 | 7,415 | 812 | 1,381 | 0 |
| 30 Jun 23 | 7,808 | 668 | 1,392 | 0 |
| 31 Mar 23 | 8,068 | 680 | 1,415 | 0 |
| 31 Dec 22 | 8,487 | 756 | 1,459 | 0 |
| 30 Sep 22 | 8,757 | 1,128 | 1,492 | 0 |
| 30 Jun 22 | 8,773 | 1,229 | 1,446 | 0 |
| 31 Mar 22 | 8,533 | 1,776 | 1,337 | 0 |
| 31 Dec 21 | 8,170 | 1,725 | 1,310 | 0 |
| 30 Sep 21 | 7,813 | 1,446 | 1,164 | 0 |
| 30 Jun 21 | 7,414 | 1,315 | 1,127 | 0 |
| 31 Mar 21 | 6,486 | 574 | 1,065 | 0 |
| 31 Dec 20 | 5,880 | 454 | 1,037 | 0 |
| 30 Sep 20 | 5,472 | 437 | 1,018 | 0 |
| 30 Jun 20 | 5,003 | 341 | 990 | 0 |
| 31 Mar 20 | 5,101 | 434 | 980 | 0 |
| 31 Dec 19 | 5,012 | 406 | 948 | 0 |
| 30 Sep 19 | 4,789 | -21 | 919 | 0 |
| 30 Jun 19 | 4,993 | 327 | 929 | 0 |
| 31 Mar 19 | 5,016 | 425 | 919 | 0 |
| 31 Dec 18 | 4,949 | 432 | 899 | 0 |
| 30 Sep 18 | 4,789 | 658 | 869 | 0 |
| 30 Jun 18 | 4,296 | 365 | 825 | 0 |
| 31 Mar 18 | 4,045 | 223 | 807 | 0 |
| 31 Dec 17 | 3,991 | 185 | 801 | 0 |
| 30 Sep 17 | 3,917 | 125 | 785 | 0 |
| 30 Jun 17 | 3,864 | 72 | 761 | 0 |
| 31 Mar 17 | 3,960 | 47 | 761 | 0 |
| 31 Dec 16 | 3,910 | 24 | 752 | 0 |
| 30 Sep 16 | 3,836 | 50 | 757 | 0 |
| 30 Jun 16 | 3,911 | 48 | 767 | 0 |
| 31 Mar 16 | 3,863 | 85 | 754 | 0 |
| 31 Dec 15 | 3,963 | 183 | 755 | 0 |
| 30 Sep 15 | 4,048 | 221 | 731 | 0 |
| 30 Jun 15 | 4,064 | 275 | 716 | 0 |
Qualität der Erträge: DXCO3 hat einen großen einmalig Verlust von R$18.3M verbucht, der sich auf die Finanzergebnisse der letzten 12 Monate bis zum 31st March, 2026 auswirkt.
Wachsende Gewinnspanne: DXCO3Die aktuellen Gewinnspannen (0.1%) sind niedriger als im letzten Jahr (3.1%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: DXCO3Die Erträge des Unternehmens sind in den letzten 5 Jahren um 41.2% pro Jahr zurückgegangen.
Beschleunigtes Wachstum: DXCO3Das Unternehmen hat im vergangenen Jahr ein negatives Gewinnwachstum verzeichnet, so dass es nicht mit seinem 5-Jahres-Durchschnitt verglichen werden kann.
Erträge im Vergleich zur Industrie: DXCO3 hatte im vergangenen Jahr ein negatives Gewinnwachstum (-96.7%), was einen Vergleich mit dem Branchendurchschnitt Forestry (-4.9%) erschwert.
Eigenkapitalrendite
Hohe Eigenkapitalrendite: DXCO3Die Eigenkapitalrendite des Unternehmens (1%) wird als niedrig angesehen.
Kapitalrendite
Rendite auf das eingesetzte Kapital
Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/22 19:05 |
| Aktienkurs zum Tagesende | 2026/05/21 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Dexco S.A. wird von 15 Analysten beobachtet. 10 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Guilherme Rosito | BofA Global Research |
| Rafael Barcellos | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |
| Carlos Palhares Sequeira | BTG Pactual |